Option Care Health (NASDAQ:OPCH) Stock Rating Lowered by Wall Street Zen

Option Care Health (NASDAQ:OPCH) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday.

OPCH has been the subject of several other reports. Barrington Research upped their target price on Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a report on Friday, January 16th. Stephens raised Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Tuesday, January 13th. Deutsche Bank Aktiengesellschaft lifted their target price on Option Care Health from $31.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, December 9th. Finally, Truist Financial set a $40.00 price target on shares of Option Care Health in a research report on Tuesday, January 13th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $37.58.

Option Care Health Stock Performance

NASDAQ OPCH opened at $32.46 on Friday. The company has a fifty day moving average price of $33.99 and a 200-day moving average price of $30.60. The firm has a market cap of $5.08 billion, a price-to-earnings ratio of 25.36, a PEG ratio of 1.82 and a beta of 0.85. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.53 and a quick ratio of 0.96. Option Care Health has a 1 year low of $24.24 and a 1 year high of $36.80.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.46. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The company had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. During the same period last year, the firm earned $0.44 earnings per share. The firm’s revenue was up 8.8% on a year-over-year basis. As a group, equities research analysts predict that Option Care Health will post 1.22 EPS for the current fiscal year.

Institutional Investors Weigh In On Option Care Health

Several institutional investors have recently added to or reduced their stakes in the business. Cornerstone Investment Partners LLC raised its position in shares of Option Care Health by 3.4% in the fourth quarter. Cornerstone Investment Partners LLC now owns 9,773 shares of the company’s stock valued at $311,000 after purchasing an additional 318 shares during the period. Sheets Smith Wealth Management grew its stake in Option Care Health by 1.3% in the 4th quarter. Sheets Smith Wealth Management now owns 26,167 shares of the company’s stock valued at $834,000 after buying an additional 326 shares in the last quarter. UMB Bank n.a. grew its stake in Option Care Health by 23.5% in the 4th quarter. UMB Bank n.a. now owns 1,715 shares of the company’s stock valued at $55,000 after buying an additional 326 shares in the last quarter. Teton Advisors Inc. raised its holdings in Option Care Health by 2.2% during the 2nd quarter. Teton Advisors Inc. now owns 17,368 shares of the company’s stock valued at $564,000 after acquiring an additional 368 shares during the period. Finally, Assetmark Inc. lifted its position in shares of Option Care Health by 1.6% during the second quarter. Assetmark Inc. now owns 26,690 shares of the company’s stock worth $867,000 after acquiring an additional 416 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.